Results 171 to 180 of about 1,494 (190)

Blastic plasmacytoid dendritic cell neoplasm (BPDCN): A promising future in the era of targeted therapeutics

Cancer, 2022
Naveen Pemmaraju, Nathaniel R Wilson, Ijele Adimora   +2 more
exaly  

Expert Opinion on Pharmacotherapy

Expert Opinion on Pharmacotherapy, 2022
Naveen Pemmaraju, Nathaniel R Wilson
exaly  

CD123-directed allogeneic chimeric-antigen receptor T-cell therapy (CAR-T) in blastic plasmacytoid dendritic cell neoplasm (BPDCN): Clinicopathological insights

Leukemia Research, 2022
Mark G Frattini, Julianne Smith
exaly  

Role of tagraxofusp in treating blastic plasmacytoid dendritic cell neoplasm (BPDCN)

Expert Opinion on Biological Therapy, 2020
Mansour Alfayez, Naveen Pemmaraju, Marina Konopleva   +2 more
exaly  

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Initial Results of a Novel, Ongoing BPDCN International Registry Program

2023
Voskanyan, A, Badikyan, M, Konopleva, M, Alencar, A, Ivanyan, A, Owen, C, Sergi, C, Kazandjian, D, Attardi, E, Tekkesin, F, Ghali, H, Bedirian, K, Martelli, MP, Voso, MT, Abramashvili, M, Al-Jadiry, M, Michael, M, Martirosyan, N, Totogashvili, N, Kotoucek, P, Kebudi, R, Ohannessian, R, Papyan, R, Elashwah, S, Bakhshi, S, Bardakhchyan, S, Danelyan, S, El-Ashwah, S, Kutluk, T, Tamamyan, G, Pemmaraju, N   +30 more
openaire   +1 more source

Daratumumab-based therapy after prior Azacytidine-Venetoclax in an octagenerian female with BPDCN (blastic plasmacytoid dendritic cell neoplasm) – a new perspective

Leukemia and Lymphoma, 2021
Rayaz Ahmed, Dinesh Bhurani, Narendra Agrawal   +2 more
exaly  

Cytogenetic Findings in a Case of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN).

Journal of the Association of Genetic Technologists
Blastic plasmacytoid dendritic cell neoplasm (BPDCN), previously known as natural killer (NK) cell leukemia/lymphoma, is categorized by the World Health Organization as a sole entity. Most often, BPDCN presents with features of both lymphoma and leukemia. The average age at diagnosis is 60 to 70 years and there are more men than women who are diagnosed
Carlos A, Tirado, John, Reinartz, Katherine, Lapp, Diane, Zhao, Andrew M, Nguyen, Kevin, Stieglbauer   +5 more
openaire   +1 more source

BPDCN: die frühe Diagnose ist entscheidend

Schweizerische Ärztezeitung
Werner Kempf, Antonio Cozzio, Stefan Dirnhofer, Emmanuella Guenova, Vera Ulrike Bacher, Mathias Schmid, Gerasimos Tsilimidos, Sabine Blum, Alexandre Theocharides   +8 more
openaire   +1 more source

Blastic Plasmacytoid Dendritic Cell Neoplasms (BPDCN)

2017
openaire   +1 more source

Novel Pathways and Potential Therapeutic Strategies for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): CD123 and Beyond

Current Hematologic Malignancy Reports, 2017
Naveen Pemmaraju
exaly